DE2855698C2 - - Google Patents

Info

Publication number
DE2855698C2
DE2855698C2 DE19782855698 DE2855698A DE2855698C2 DE 2855698 C2 DE2855698 C2 DE 2855698C2 DE 19782855698 DE19782855698 DE 19782855698 DE 2855698 A DE2855698 A DE 2855698A DE 2855698 C2 DE2855698 C2 DE 2855698C2
Authority
DE
Germany
Prior art keywords
urokinase
molecular weight
solution
activity
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19782855698
Other languages
German (de)
English (en)
Other versions
DE2855698A1 (de
Inventor
Tadakazu Kyoto Jp Suyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Priority to DE19782855698 priority Critical patent/DE2855698A1/de
Publication of DE2855698A1 publication Critical patent/DE2855698A1/de
Application granted granted Critical
Publication of DE2855698C2 publication Critical patent/DE2855698C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19782855698 1978-12-22 1978-12-22 Verfahren zur herstellung eines urokinase mit einem molekulargewicht von 54 000 + 10 000 enthaltenden praeparats und seine verwendung als fibrinolytikum und thrombolytikum Granted DE2855698A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19782855698 DE2855698A1 (de) 1978-12-22 1978-12-22 Verfahren zur herstellung eines urokinase mit einem molekulargewicht von 54 000 + 10 000 enthaltenden praeparats und seine verwendung als fibrinolytikum und thrombolytikum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782855698 DE2855698A1 (de) 1978-12-22 1978-12-22 Verfahren zur herstellung eines urokinase mit einem molekulargewicht von 54 000 + 10 000 enthaltenden praeparats und seine verwendung als fibrinolytikum und thrombolytikum

Publications (2)

Publication Number Publication Date
DE2855698A1 DE2855698A1 (de) 1980-07-03
DE2855698C2 true DE2855698C2 (fr) 1988-07-21

Family

ID=6058136

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782855698 Granted DE2855698A1 (de) 1978-12-22 1978-12-22 Verfahren zur herstellung eines urokinase mit einem molekulargewicht von 54 000 + 10 000 enthaltenden praeparats und seine verwendung als fibrinolytikum und thrombolytikum

Country Status (1)

Country Link
DE (1) DE2855698A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2545231B2 (ja) * 1987-06-18 1996-10-16 日本ケミカルリサ−チ株式会社 ウロキナ−ゼの加熱による低分子化抑制法
EP0299715A3 (fr) * 1987-07-13 1990-07-04 MITSUI TOATSU CHEMICALS, Inc. Procédé de production de L-tryptophane
DE19856443A1 (de) * 1998-12-08 2000-06-21 Centeon Pharma Gmbh Stabilisiertes Antithrombin III-Präparat

Also Published As

Publication number Publication date
DE2855698A1 (de) 1980-07-03

Similar Documents

Publication Publication Date Title
DE3240174C2 (fr)
DE69213421T2 (de) Verfahren zur Herstellung eines aktivierten Faktor VII-Konzentrates mit einer hohen Reinheit
DE3877529T2 (de) Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
DE3400413C2 (fr)
CH645537A5 (en) Antithrombin product and process for its production
DE2734821B2 (de) Blutgerinnungsfördernde Präparation und Verfahren zu ihrer Herstellung
EP0124506A2 (fr) Procédé pour inactiver des pathogènes
DE3809991A1 (de) Verfahren zur waermebehandlung von thrombin
DE3043409C2 (fr)
DE2715832C3 (de) Verfahren zur Gewinnung von gereinigtem antihämophilem Globulin A (Faktor VIII)
DE2459915C3 (de) Aktive Verbindung des Plasminogen- Typs, Verfahren zu ihrer Reinigung und ihre Verwendung
EP0271885B1 (fr) Médicament contenant la protéine tissulaire PP4, procédé de préparation de PP4 et sa pasteurisation et l'utilisation de PP4
DE2440529B2 (de) Hyaluronidase-Präparat aus menschlicher Plazenta
EP0111777B1 (fr) Solution de protéines du plasma ayant une activité coagulante, son procédé de préparation et son utilisation pour le traitement des troubles du système hémostatique
EP0137428B1 (fr) Procédé de pasteurisation du plasma ou de concentrés de facteurs II, VII, IX et X de coagulation du sang
DE69231401T2 (de) Herstellung von faktor-ix
EP0065256A2 (fr) Procédé de préparation de plasminogène et plasminogène ainsi préparé
DE2456589A1 (de) Verfahren zur herstellung eines plasminogen-aktivators und denselben enthaltendes mittel
DE2855698C2 (fr)
DE2500810A1 (de) Reinigen von plasminogen
DE1442134C3 (de) In vivo antikoagulierend wirkendes und defibrinierendes Enzym
DE2715748C3 (de) Gereinigte aktive Verbindung des Plasminogen-Typs menschlichen Ursprungs und ihre Verwendung
DE3586952T2 (de) Fibrinophiler urokinase-komplex und dessen herstellung.
DE3306944A1 (de) Fibrinolytisch aktives mittel und verfahren zu seiner herstellung
DE1617279C3 (de) Verfahren zur Herstellung eines die Aspergillopeptidase ARL 1 enthaltenden Präparates aus Aspergillus oryzae und sie enthaltendes Arzneimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT. TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN

8328 Change in the person/name/address of the agent

Free format text: TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee